Market
Will 'EnteroMix' clinical trials be completed by June 30, 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Updates from the Russian Ministry of Health or major news outlets covering clinical trials
Story
Russia to Launch Free Cancer Vaccine 'EnteroMix' in 2025, Costs 300,000 Rubles per Dose, Says Andrei Kaprin
Dec 17, 2024, 10:30 AM
Russia has announced the development of a cancer vaccine, which will be launched for free in 2025. The vaccine, referred to as 'EnteroMix', is designed specifically for cancer patients and will be personalized for each individual. Andrei Kaprin, the chief oncologist of the Ministry of Health, stated that the state will incur a cost of 300,000 rubles per dose. The selection process for clinical trial candidates has already begun, as reported by Kaprin on his Telegram channel. This initiative reflects Russia's commitment to making advanced medical treatments accessible to its population.
View original story
Similar markets
Unsuccessful • 25%
Partially successful • 25%
Successful with expected results • 25%
Results inconclusive • 25%
25% to 50% • 25%
Less than 25% • 25%
51% to 75% • 25%
More than 75% • 25%
Breast Cancer • 25%
Colorectal Cancer • 25%
Lung Cancer • 25%
Other • 25%
Manufacturing issues • 25%
Regulatory hurdles • 25%
Supply chain disruptions • 25%
Other • 25%
No • 50%
Yes • 50%
Moderate improvement • 25%
Significant improvement • 25%
Worsening condition • 25%
No improvement • 25%
